Literature DB >> 19351574

Association study of polymorphisms in the group III metabotropic glutamate receptor genes, GRM4 and GRM7, with schizophrenia.

Hiroki Shibata1, Ayako Tani, Tomoyuki Chikuhara, Rumiko Kikuta, Mayumi Sakai, Hideaki Ninomiya, Nobutada Tashiro, Nakao Iwata, Norio Ozaki, Yasuyuki Fukumaki.   

Abstract

Based on the hypothesis that a glutamatergic dysfunction is involved in the pathophysiology of schizophrenia, we have been conducting systematic studies on the association between glutamate receptor genes and schizophrenia. Here we report association studies of schizophrenia with polymorphisms in group III metabotropic glutamate receptor genes, GRM4 and GRM7. We selected 8 and 43 common SNPs distributed in the entire gene regions of GRM4 (>111 kb) and GRM7 (>900 kb), respectively. We scanned significant associations with schizophrenia using 100 case-control pairs of Japanese. We identified two neighboring SNPs (rs12491620 and rs1450099) in GRM7 showing highly significant haplotype association with schizophrenia surviving the FDR correction. We then performed additional typing of the two SNPs using the expanded sample set (404 cases and 420 controls) and confirmed the significant association with the disease. We conclude that at least one susceptibility locus for schizophrenia is located within or nearby GRM7, whereas GRM4 is unlikely to be a major susceptibility gene for schizophrenia in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351574     DOI: 10.1016/j.psychres.2007.12.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  17 in total

Review 1.  Practical Strategies and Concepts in GPCR Allosteric Modulator Discovery: Recent Advances with Metabotropic Glutamate Receptors.

Authors:  Craig W Lindsley; Kyle A Emmitte; Corey R Hopkins; Thomas M Bridges; Karen J Gregory; Colleen M Niswender; P Jeffrey Conn
Journal:  Chem Rev       Date:  2016-02-16       Impact factor: 60.622

2.  Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.

Authors:  Kun Wang; Jinmin Zhao; Maolin He; Mitra Fowdur; Tenglong Jiang; Shuju Luo
Journal:  Tumour Biol       Date:  2015-08-15

3.  Mutant mouse models: genotype-phenotype relationships to negative symptoms in schizophrenia.

Authors:  Colm M P O'Tuathaigh; Brian P Kirby; Paula M Moran; John L Waddington
Journal:  Schizophr Bull       Date:  2009-11-24       Impact factor: 9.306

4.  The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.

Authors:  E Sacchetti; C Magri; A Minelli; P Valsecchi; M Traversa; S Calza; A Vita; M Gennarelli
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

5.  Test for association of common variants in GRM7 with alcohol consumption.

Authors:  Whitney E Melroy-Greif; Csaba Vadasz; Helen M Kamens; Matthew B McQueen; Robin P Corley; Michael C Stallings; Christian J Hopfer; Kenneth S Krauter; Sandra A Brown; John K Hewitt; Marissa A Ehringer
Journal:  Alcohol       Date:  2016-08-31       Impact factor: 2.405

6.  The identification and functional implications of human-specific "fixed" amino acid substitutions in the glutamate receptor family.

Authors:  Hiroki Goto; Kazunori Watanabe; Naozumi Araragi; Rui Kageyama; Kunika Tanaka; Yoko Kuroki; Atsushi Toyoda; Masahira Hattori; Yoshiyuki Sakaki; Asao Fujiyama; Yasuyuki Fukumaki; Hiroki Shibata
Journal:  BMC Evol Biol       Date:  2009-09-08       Impact factor: 3.260

7.  MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia.

Authors:  Chi-Yu Lai; Sung-Liang Yu; Ming H Hsieh; Chun-Houh Chen; Hsuan-Yu Chen; Chun-Chiang Wen; Yung-Hsiang Huang; Po-Chang Hsiao; Chuhsing Kate Hsiao; Chih-Min Liu; Pan-Chyr Yang; Hai-Gwo Hwu; Wei J Chen
Journal:  PLoS One       Date:  2011-06-29       Impact factor: 3.240

8.  An ICA with reference approach in identification of genetic variation and associated brain networks.

Authors:  Jingyu Liu; Mohammad M Ghassemi; Andrew M Michael; David Boutte; William Wells; Nora Perrone-Bizzozero; Fabio Macciardi; Daniel H Mathalon; Judith M Ford; Steven G Potkin; Jessica A Turner; Vince D Calhoun
Journal:  Front Hum Neurosci       Date:  2012-02-22       Impact factor: 3.169

9.  Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants.

Authors:  Li Yang; Benjamin M Neale; Lu Liu; S Hong Lee; Naomi R Wray; Ning Ji; Haimei Li; Qiujin Qian; Dongliang Wang; Jun Li; Stephen V Faraone; Yufeng Wang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-05-31       Impact factor: 3.568

10.  Therapeutic potential of metabotropic glutamate receptor modulators.

Authors:  N Hovelsø; F Sotty; L P Montezinho; P S Pinheiro; K F Herrik; A Mørk
Journal:  Curr Neuropharmacol       Date:  2012-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.